FrancophonIA/ELRC3.0 huggingface dataset:
English: If you become pregnant while taking Clopidogrel BGR, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Croatian: Ako zatrudnite za vrijeme uzimanja Clopidogrel BGRa, odmah se posavjetujte s liječnikom, jer nije preporučeno uzimati klopidogrel za vrijeme trudnoće.
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel BGR in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Croatian: Ako ste imali jaku bol u prsištu (nestabilna angina ili srčani udar), liječnik Vam može propisati Clopidogrel BGR u kombinaciji s acetilsalicilatnom kiselinom, tvari prisutne u mnogim lijekovima za ublažavanje boli i snižavanje temperature.
English: Then, the recommended dose is one 75 mg tablet of Clopidogrel BGR per day as described above.
Croatian: Nakon toga, preporučena doza lijeka Clopidogrel BGR je jedna tableta od 75 mg dnevno, kao što je opisano iznad.
English: HDPE bottle (volume: 15 ml), PP closure with a desiccant: 30 film-coated tablets in a box.
Croatian: HDPE boca (volumen: 15 ml), PP zatvarač sa sredstvom za sušenje: 30 filmom obloženih tableta u kutiji.
English: ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
Croatian: 35 dana), ishemijski moždani udar (u rasponu od 7 dana do najviše 6 mjeseci) ili imaju utvrđenu bolest perifernih arterija.
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopiodgrel BGR (4 tablets of 75 mg) once at the start of treatment.
Croatian: Ako ste imali jake bolove u prsištu (nestabilna angina ili srčani udar), liječnik Vam u početku liječenja može jednokratno dati 300 mg lijeka Clopidogrel BGR (4 tablete od po 75 mg).
English: Driving and using machines Clopidogrel BGR is unlikely to affect your ability to drive or to use machines.
Croatian: Upravljanje vozilima i strojevima Clopidogrel BGR ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima ili strojevima.
English: The recommended dose, including for patients with a condition called ‘atrial fibrillation' (an irregular heartbeat), is one 75 mg tablet of Clopidogrel BGR per day to be taken orally with or without food, and at the same time each day.
Croatian: Preporučena doza, uključujući za bolesnike sa stanjem zvanim ‘fibrilacija atrija' (nepravilni otkucaji srca), Clopidogrel BGRa je jedna tableta od 75 mg dnevno koja se uzima kroz usta s obrokom ili između obroka, u isto vrijeme svaki dan.
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel BGR.
Croatian: Ako ste trudni ili sumnjate na trudnoću, obavjestite svog liječnika ili ljekarnika prije nego što uzmete Clopidogrel BGR.
English: HDPE bottle (volume: 150 ml), PP closure with a desiccant: 500 film-coated tablets in a box.
Croatian: HDPE boca (volumen 150 ml), PP zatvarač sa sredstvom za sušenje: 500 filmom obloženih tableta u kutiji.
English: - The other ingredients are lactose (see section 2 ‘Clopidogrel BGR contains lactose'), microcrystalline cellulose, pregelatinised maize starch, macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose (E464), titanium dioxide (E171), red iron oxide (E172), talc and propylene glycol in the film-coating.
Croatian: Drugi sastojci su laktoza (vidjeti dio 2 'Clopidogrel BGR sadrži laktozu'), mikrokristalična celuloza, prethodno geliran škrob, makrogol 6000 i hidrogenirano ricinusovo ulje u jezgri tablete, te hipromeloza (E464), titanijev dioksid (E171), crveni željezov oksid (E172), talk i propilenglikol u film ovojnici tablete (vidjeti dio 2.).
English: What you need to know before you take Clopidogrel BGR
Croatian: Što morate znati prije nego počnete uzimati Clopidogrel BGR
English: Clopidogrel BGR is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
Croatian: Clopidogrel BGR uzimaju odrasli za sprječavanje stvaranja krvnih ugrušaka (tromba) u otvrdnutim krvnim žilama (arterijama), a taj poremećaj zove se aterotromboza i može dovesti do aterotrombotičkih događaja (kao što su moždani udar, srčani udar ili smrt).
English: 30 film-coated tablets: EU/1/09/558/011 500 film-coated tablets: EU/1/09/558/012
Croatian: 30 filmom obloženih tableta: EU/1/09/558/011 500 filmom obloženih tableta: EU/1/09/558/012
English: Other medicines and Clopidogrel BGR
Croatian: Drugi lijekovi i Clopidogrel BGR
English: You should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as: - oral anticoagulants, medicines used to reduce blood clotting, - a non-steroidal anti-inflammatory medicine, usually used to treat painful and/or inflammatory conditions of muscle or joints, - heparin or any other injectable medicine used to reduce blood clotting, - ticlopidine, other antiplatelet agent, - a selective serotonin reuptake inhibitor (including but not restricted to fluoxetine or fluvoxamine), medicines usually used to treat depression, - omeprazole or esomeprazole, medicines to treat upset stomach, - fluconazole or voriconazole, medicines to treat fungal infections, - efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
Croatian: Posebno je važno obavijestiti liječnika ako uzimate - lijekove koji mogu povećati rizik od krvarenja, na primjer: - oralne antikoagulanse, lijekove koji smanjuju zgrušavanje krvi, - nesteroidne protuupalne lijekove, koji se obično primjenjuju za liječenje bolnih i/ili upalnih stanja mišića ili zglobova, - heparin ili bilo koji drugi lijek koji se daje putem injekcije za smanjivanje zgrušavanja krvi, - tiklopidin, drugi antitrombocitni lijek, - selektivne inhibitore ponovne pohrane serotonina (uključujući, ali ne ograničeno na fluoksetin ili fluvoksamin), lijekove koji se obično koriste za liječenje depresije, - omeprazol ili esomeprazol, lijekove za smanjenje želučanih tegoba, - flukonazol ili vorikonazol, lijekove koji se primjenjuju za liječenje gljivičnih infekcija, - efavirenz, lijek koji se primjenjuje za liječenje HIV (virus humane imunodeficijencije) infekcija, - karbamazepin, lijek koji se primjenjuje za liječenje nekih oblika epilepsije, - moklobemid, lijek za liječenje depresije, - repaglinid, lijek za liječenje dijabetesa, - paklitaksel, lijek za liječenje raka,
English: 7 film-coated tablets: EU/1/09/558/001 14 film-coated tablets: EU/1/09/558/002 28 film-coated tablets: EU/1/09/558/003 30 film-coated tablets: EU/1/09/558/004 50 film-coated tablets: EU/1/09/558/005 56 film-coated tablets: EU/1/09/558/006 60 film-coated tablets: EU/1/09/558/007 84 film-coated tablets: EU/1/09/558/008 90 film-coated tablets: EU/1/09/558/009 100 film-coated tablets: EU/1/09/558/010
Croatian: 7 filmom obloženih tableta: EU/1/09/558/001 14 filmom obloženih tableta: EU/1/09/558/002 28 filmom obloženih tableta: EU/1/09/558/003 30 filmom obloženih tableta: EU/1/09/558/004 50 filmom obloženih tableta: EU/1/09/558/005 56 filmom obloženih tableta: EU/1/09/558/006 60 filmom obloženih tableta: EU/1/09/558/007 84 filmom obložene tablete: EU/1/09/558/008 90 filmom obloženih tableta: EU/1/09/558/009 100 filmom obloženih tableta: EU/1/09/558/010
English: Clopidogrel BGR contains lactose.
Croatian: Clopidogrel BGR sadrži laktozu.
English: If you forget to take Clopidogrel BGR
Croatian: Ako ste zaboravili uzeti Clopidogrel BGR
English: • You should tell your doctor if a surgery (including dental) is planned.
Croatian: Dok uzimate Clopidogrel BGR: - Obavijestite svog liječnika ako planirate kirurški zahvat (uključujući stomatološke zahvate).
English: Each film-coated tablet contains 75 mg of clopidogrel (as hydrogen sulphate).
Croatian: Svaka filmom obložena tableta sadrži 75 mg klopidogrela (u obliku klopidogrelhidrogensulfata).
English: Bottle
Croatian: Boca
English: Clopidogrel BGR 75 mg film-coated tablets clopidogrel
Croatian: Clopidogrel BGR 75 mg filmom obložene tablete klopidogrel
English: You have been prescribed Clopidogrel BGR to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease.
Croatian: Clopidogrel BGR Vam je propisan za sprječavanje stvaranja krvnih ugrušaka i smanjivanje opasnosti od ovih ozbiljnih događaja jer: - imate otvrdnuće arterija (koje se još zove ateroskleroza) te - ste već imali srčani udar, moždani udar ili imate stanje koje se zove bolest perifernih arterija. - ste imali teški oblik boli u prsištu, poznat pod nazivom “nestabilna angina” ili “infarkt miokarda” (srčani udar).
English: • Paediatric population Clopidogrel should not be used in children because of efficacy concerns (see section 5.1).
Croatian: - Pedijatrijska populacija - Klopidogrel se ne primjenjuje u djece zbog nedovoljnih podataka o djelotvornosti (vidjeti dio
English: Clopidogrel BGR 75 mg film-coated tablets
Croatian: Clopidogrel BGR 75 mg filmom obložene tablete
English: 30 film-coated tablets 500 film-coated tablets
Croatian: 30 filmom obloženih tableta 500 filmom obloženih tableta
English: Laboratoires BIOGARAN 15, boulevard Charles de Gaulle - 92707 Colombes Cedex, France
Croatian: Laboratoires BIOGARAN 15, boulevard Charles de Gaulle - 92707 Colombes Cedex, Francuska
English: If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel BGR.
Croatian: Ako se bilo što od navedenog odnosi na Vas, ili niste sigurni, obratite se svom liječniku prije uzimanja Clopidogrel BGRa.
English: Clopidogrel BGR contains lactose
Croatian: Clopidogrel BGR sadrži laktozu
English: Secondary prevention of atherothrombotic events
Croatian: Prevencija aterotrombotičkih i tromboembolijskih događaja u fibrilaciji atrija
English: Laboratoires BIOGARAN 15, boulevard Charles de Gaulle 92707 Colombes Cedex France
Croatian: Laboratoires BIOGARAN 15, boulevard Charles de Gaulle 92707 Colombes Cedex Francuska
English: 500 film-coated tablets
Croatian: 500 filmom obloženih tableta
English: Therapeutic experience is limited in patients with moderate hepatic disease who may have bleeding diatheses (see section 4.4).
Croatian: - Terapijsko iskustvo u bolesnika s umjereno narušenom funkcijom jetre koji mogu imati hemoragijsku dijatezu je ograničeno (vidjeti dio 4.4).
English: Musculo skeletal bleeding (haemarthrosis), arthritis, arthralgia, myalgia
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva mišićnokoštano krvarenje (hemartroza), artritis, artralgija, mijalgija
English: • Renal impairment Therapeutic experience is limited in patients with renal impairment (see section 4.4).
Croatian: - Terapijsko iskustvo u bolesnika s narušenom funkcijom bubrega je ograničeno (vidjeti dio 4.4).
English: Marketing Authorisation Holder Laboratoires BIOGARAN 15, boulevard Charles de Gaulle 92707 Colombes Cedex France
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Laboratoires BIOGARAN 15, boulevard Charles de Gaulle 92707 Colombes Cedex
English: How to take Clopidogrel BGR
Croatian: Kako uzimati Clopidogrel BGR
English: Do not stop the treatment unless your doctor tells you so.
Croatian: Ako prestanete uzimati Clopidogrel BGR Ne prekidajte liječenje osim ako Vam to ne savjetuje liječnik.
English: How to store Clopidogrel BGR
Croatian: Kako čuvati Clopidogrel BGR
English: - You have an irregular heartbeat, a condition called ‘atrial fibrillation', and you cannot take medicines known as ‘oral anticoagulants' (vitamin K antagonists) which prevent new clots from forming and prevent existing clots from growing.
Croatian: Liječnik će Vam propisati i acetilsalicilatnu kiselinu (tvar koju sadrže mnogi lijekovi za ublažavanje boli i snižavanje povišene temperature, kao i oni za sprječavanje stvaranja krvnih ugrušaka). - imate nepravilne otkucaje srca, stanje koje se zove "fibrilacija atrija", a ne možete uzimati lijekove poznate kao 'oralni antikoagulansi' (antagonisti vitamina K), koji sprječavaju stvaranje novih ugrušaka te rast postojećih ugrušaka.
English: For blister Store in the original package in order to protect from moisture and light.
Croatian: Za blister Čuvati u originalnom pakiranju radi zaštite od vlage i svjetlosti.
English: Blister Store in the original package in order to protect from moisture and light.
Croatian: Blister Lijek čuvati u originalnom pakiranju radi zaštite od vlage i svjetlosti.
English: • if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer) - a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body).
Croatian: Nemojte uzimati Clopidogrel BGR - ako ste alergični na klopidogrel ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.) - ako imate poremećaj koji izaziva krvarenje, kao što je, primjerice, želučani čir ili krvarenje u mozgu - ako patite od teške bolesti jetre.
English: What you need to know before you take Clopidogrel BGR 3.
Croatian: Što je Clopidogrel BGR i za što se koristi Što morate znati prije nego počnete uzmati Clopidogrel BGR Kako uzimati Clopidogrel BGR Moguće nuspojave
English: Its effect may improve further for up to six months.
Croatian: Njegov učinak može se nadalje poboljšati tijekom sljedećih šest mjeseci.
English: The medicine usually starts to have an effect after four to six weeks.
Croatian: Lijek obično počinje djelovati nakon četiri do šest tjedana.
English: It is available as tablets (10, 15 and 20 mg).
Croatian: Dostupan je u obliku tableta (10, 15 i 20 mg).
English: EMA/CHMP/328573/2014 EMEA/H/C/001227
Croatian: EMA/265372/2014 EMEA/H/C/001227
English: The full EPAR for the reference medicine can also be found on the Agency's website.
Croatian: Cjeloviti EPAR za referentni lijek se također može naći na internetskim stranicama Agencije.
English: The full EPAR for Leflunomide medac can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za Leflunomide medac može se pronaći na mrežnoj stranici Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Leflunomide medac leflunomide
Croatian: Leflunomide medac leflunomid
English: This means that Leflunomide medac is similar to a ‘reference medicine' already authorised in the European Union (EU) called Arava.
Croatian: To znači da je Leflunomide medac sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Arava.
English: Leflunomide medac EMA/CHMP/328573/2014
Croatian: Leflunomide medac EMA/265372/2014
English: Leflunomide medac treatment usually starts with a ‘loading dose' of 100 mg once a day for three days, followed by a maintenance dose.
Croatian: Liječenje lijekom Leflunomide medac obično započinje „udarnom dozom” od 100 mg na dan jednom dnevno tijekom tri dana, nakon čega slijedi doza održavanja.
English: The recommended maintenance dose is 10 to 20 mg once a day in patients with rheumatoid arthritis, and 20 mg once a day in patients with psoriatic arthritis.
Croatian: Preporučena doza održavanja je od 10 do 20 mg jednom dnevno za bolesnike s reumatoidnim artritisom, te 20 mg jednom dnevno za bolesnike s psorijatičnim artritisom.
English: It reduces inflammation by reducing the production of immune cells called ‘lymphocytes', which are responsible for inflammation.
Croatian: Smanjuje upalu smanjenjem proizvodnje imunoloških stanica zvanih „limfociti” koji su odgovorni za upalu.
English: Leflunomide medac is used to treat adults with active rheumatoid arthritis (an immune system disease causing inflammation of the joints) or active psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints).
Croatian: Leflunomide medac koristi se za liječenje odraslih bolesnika s aktivnim reumatoidnim artritisom (bolest imunološkog sustava koja uzrokuje upalu zglobova) ili aktivnim psorijatičnim artritisom (bolest koja uzrokuje crvene, ljuskave mrljaste naslage na koži i upalu zglobova).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Leflunomide medac on 27 July 2010.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje za Leflunomid medac vrijedi na prostoru Europske unije od 27. srpnja 2010.
English: For more information about treatment with Leflunomide medac, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Leflunomide medac pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: Therefore, the CHMP's view was that, as for Arava, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a da, kao i kod lijeka Arava, koristi nadmašuju utvrđene rizike.
English: Leflunomide does this by blocking an enzyme called ‘dihydroorotate dehydrogenase', which is necessary for the lymphocytes to multiply.
Croatian: Leflunomide to čini blokadom enzima zvanog „dihidroorotat dehidrogenaza” koji je potreban za razmnožavanje limfocita.
English: The doctor should carry out blood tests to check the patient's liver, white blood cell counts and platelet counts before prescribing Leflunomide medac, and regularly during treatment.
Croatian: Liječnik treba provesti krvne pretrage kako bi provjerio bolesnikova jetra, broj leukocita i trombocita prije propisivanja lijeka Leflunomide medac te redovito tijekom liječenja.
English: A risk management plan has been developed to ensure that Leflunomide medac is used as safely as possible.
Croatian: Razvijen je plan upravljanja rizicima kako bi se osigurala što sigurnija uporaba lijeka Leflunomide medac.
English: With fewer lymphocytes, there is less inflammation, helping to control the symptoms of arthritis.
Croatian: Smanjenje broja limfocita ublažava upalu, što pomaže pri kontroli simptoma artritrisa.
English: Leflunomide medac treatment should be started and supervised by a specialist who has experience in the treatment of rheumatoid arthritis and psoriatic arthritis.
Croatian: Liječenje lijekom Leflunomide medac treba započeti i nadzirati specijalist iskusan u liječenju reumatoidnog artritisa i psorijatičnog artritisa.
English: Leflunomide medac is a ‘generic medicine'.
Croatian: Leflunomide medac je „generički lijek”.
English: Other information about Leflunomide medac:
Croatian: Ostale informacije o lijeku Leflunomide medac:
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Leflunomide medac.
Croatian: Objašnjava kako je Povjerenstvo za humane lijekove (CHMP) ocijenilo lijek Leflunomide medac da bi postiglo mišljenje u korist davanja odobrenja za stavljanje u promet i preporučilo uvjete za njegovu primjenu.
English: What measures are being taken to ensure the safe and effective use of Leflunomide medac ?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Leflunomide medac?
English: Because Leflunomide medac is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine's.
Croatian: Budući da je Leflunomide medac generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: This document is a summary of the European public assessment report (EPAR) for Leflunomide medac.
Croatian: Ovo je sažetak Europskog javnog izvješća o ocjeni dokumentacije o lijeku (EPAR) za lijek Leflunomide medac.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Leflunomide medac, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana u sažetak opisa svojstava lijeka kao i u uputu o lijeku Leflunomide medac uključene su sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Because Leflunomide medac is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Arava.
Croatian: Budući da je Leflunomide medac generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje da je lijek bioekvivalentan referentnom lijeku Arava.
English: What are the benefit and risk of Leflunomide medac?
Croatian: Koje su koristi i rizici lijeka Leflunomide medac?
English: The active substance in Leflunomide medac, leflunomide, is an immunosuppressant.
Croatian: Djelatna tvar u lijeku Leflunomide medac, leflunomid je imunosupresiv.
English: Leflunomide medac is a medicine that contains the active substance leflunomide.
Croatian: Leflunomide medac je lijek koji sadrži djelatnu tvar leflunomid.
English: The CHMP concluded that, in accordance with EU requirements, Leflunomide medac has been shown to have comparable quality and to be bioequivalent to Arava.
Croatian: Povjerenstvo za lijekove za primjenu kod ljudi (CHMP) pri Agenciji zaključilo je kako je, u skladu sa zahtjevima EU-a, potvrđeno kako Leflonomide medac posjeduje usporedivu kakvoću te je bioekvivalentan/usporediv s lijekom Arava.
English: Why has Leflunomide medac been approved?
Croatian: Zašto je Leflunomide medac odobren?
English: The Committee recommended that Leflunomide medac be given marketing authorisation.
Croatian: Povjerenstvo preporučuje odobrenje lijeka Leflunomide medac za korištenje u EU-u.
English: What is Leflunomide medac?
Croatian: Što je Leflunomide medac?
English: What is Leflunomide medac used for?
Croatian: Za što se Leflunomide medac koristi?
English: How does Leflunomide medac work?
Croatian: Kako Leflunomide medac djeluje?
English: How is Leflunomide medac used?
Croatian: Kako se Leflunomide medac koristi?
English: How has Leflunomide medac been studied?
Croatian: Kako je Leflunomide medac ispitivan?
English: 3 x 28 tablets
Croatian: 3 x 28 tableta
English: It is available in packs of:
Croatian: Dostupan je u pakiranjima od:
English: • At the request of the European Medicines Agency;
Croatian: • Na zahtjev Europske agencije za lijekove.
English: * Definition of frequency terms: Very common - ≥ 10 %; Common - > 5 % and < 10 %.
Croatian: * Definicije pojmova učestalosti: vrlo često - ≥ 10%; često - > 5% i < 10%.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 14 September 2015
Croatian: Datum prvog odobrenja: 14. rujna 2015.
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would not be longer than 24 hours at 2 °C to 8 °C.
Croatian: Ako se ne primijeni odmah, vrijeme i uvjeti čuvanja lijeka prije primjene odgovornost su korisnika i ne bi trebali biti dulji od 24 sata na temperaturi od 2°C do 8°C.
English: Talk to your doctor or hospital pharmacist before receiving Pemetrexed Lilly.
Croatian: Obratite se svom liječniku ili bolničkom ljekarniku prije nego primite Pemetrexed Lilly.
English: Based on the planned date of your infusion of Pemetrexed Lilly and/or on the status of your kidney function, your doctor needs to advise you on which medicines you can take and when you can take them.
Croatian: Ovisno o planiranom datumu primjene infuzije lijeka Pemetrexed Lilly i/ili Vašoj bubrežnoj funkciji, liječnik Vam mora reći koje lijekove možete uzimati i kada ih možete uzimati.
English: Your doctor will discuss with you the potential risk of taking Pemetrexed Lilly during pregnancy.
Croatian: Liječnik će s Vama razgovarati o mogućem riziku primjene lijeka Pemetrexed Lilly u trudnoći.